Native valve infective endocarditis due to Micrococcus luteus in a non-Hodgkin’s lymphoma patient
Nicole M. Ianniello,
Diana C. Andrade,
Stipe Ivancic,
Paula A. Eckardt,
Juan C. Lemos Ramirez
Affiliations
Nicole M. Ianniello
Memorial Hospital West, Department of Pharmacy, Pembroke Pines, FL, United States; Corresponding authors at: 703 N Flamingo Rd, Pembroke Pines, FL, 33028, United States.
Diana C. Andrade
Memorial Hospital West, Department of Pharmacy, Pembroke Pines, FL, United States; Memorial Hospital West, Department of Infectious Disease, Pembroke Pines, FL, United States; Corresponding authors at: 703 N Flamingo Rd, Pembroke Pines, FL, 33028, United States.
Stipe Ivancic
Memorial Hospital West, Department of Internal Medicine, Pembroke Pines, FL, United States
Paula A. Eckardt
Memorial Hospital West, Department of Infectious Disease, Pembroke Pines, FL, United States
Juan C. Lemos Ramirez
Memorial Hospital West, Department of Infectious Disease, Pembroke Pines, FL, United States
Micrococcus species are typically considered contaminants from skin and mucous membranes. However, especially in severely immunocompromised patients, a blood culture with Micrococcus could be the cause of a significant infection. We report a 65-year-old female with non-Hodgkin’s lymphoma who developed native valve infective endocarditis due to Micrococcus luteus. There is no defined therapeutic regimen for infective endocarditis due to Micrococcus luteus; however, our patient was successfully treated for six weeks with vancomycin and rifampin. To our knowledge, there is only one other case report of native valve endocarditis due to Micrococcus luteus. Keywords: Non-Hodgkin’s lymphoma, Micrococcus, Native valve, Endocarditis
